Antiretroviral treatment of HIV infection does not influence HIV-specific immunity but has an impact on non-specific immune activation
Language English Country Netherlands Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
21361861
DOI
10.2174/157016211795569078
PII: BSP-CHIVR-132-2011
Knihovny.cz E-resources
- MeSH
- ADP-ribosyl Cyclase 1 biosynthesis MeSH
- CD8-Positive T-Lymphocytes immunology MeSH
- Adult MeSH
- Enzyme-Linked Immunospot Assay MeSH
- HIV Infections drug therapy immunology MeSH
- HIV immunology MeSH
- HLA-DR Antigens biosynthesis MeSH
- Interferon-gamma biosynthesis MeSH
- Interleukin-2 biosynthesis MeSH
- Anti-HIV Agents administration & dosage MeSH
- Middle Aged MeSH
- Humans MeSH
- Membrane Glycoproteins biosynthesis MeSH
- Flow Cytometry MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- ADP-ribosyl Cyclase 1 MeSH
- CD38 protein, human MeSH Browser
- HLA-DR Antigens MeSH
- Interferon-gamma MeSH
- Interleukin-2 MeSH
- Anti-HIV Agents MeSH
- Membrane Glycoproteins MeSH
HIV-specific and non-specific immune responses are crucial in the immunopathogenesis of HIV infection. Therefore, the objective of our study was to analyse the frequency and functional status of HIV-specific CD8+ T cells and the expression of non-specific activation markers on CD8+ T cells in HIV+ patients, and to assess the effects of combined antiretroviral treatment (cART). We examined 28 HIV+ patients, including 13 patients not receiving therapy and 15 patients on cART therapy using ELISpot assay and flow cytometry with intracellular and MHC tetramer staining. MHC tetramers detected HIV-specific CD8+ T cells in 6 HIV+ patients on cART and in 7 untreated individuals; the ELISpot method detected these cells in 5 untreated HIV+ individuals only. Reduced intracellular IFN-γ and IL-2 production by HIV-specific CD8+ T cells was detected in both treated and untreated HIV+ patients, and multifunctional CD8+ T cells simultaneously producing these cytokines were not found in any patient. In contrary to these findings, the percentage of CD8+ T cells expressing CD38 and HLA-DR was significantly higher in untreated patients as compared to HIV+ patients on cART. Together, these results suggest that the alterations of HIV-specific immunity are not influenced by the therapy of HIV infection; whereas, the non-specific chronic immune activation is down-regulated by cART.
References provided by Crossref.org
The Effect of Latent Toxoplasma gondii Infection on the Immune Response in HIV-Infected Patients